Centrus Is Down 69% From Its High. Is Its $4.5 Billion Backlog Enough to Buy at $143?
Centrus' backlog is nearly 10 times its projected 2026 revenue. But its revenue and EPS will decline over the next few years as its core business undergoes a capital-intensive transformation.
Centrus Energy (LEU) Surges 8.8%: Is This an Indication of Further Gains?
Centrus Energy (LEU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Centrus Energy: The Selloff Has Finally Made The Risk Worth Taking (Rating Upgrade)
Centrus Energy Corp. is now attractively valued after a 66% decline from recent highs, offering a compelling entry for nuclear energy exposure. I am considering a staged Buy of LEU stock with a 1-3% NAV allocation, recognizing high execution risk and technical volatility. My discounted earnings model suggests a 21.5% margin of safety, assuming 15% EPS CAGR over 20 years despite near-term earnings contraction.
Centrus Energy: The Backlog Is Now Real
Centrus Energy is executing ahead of schedule, with Q2 results reinforcing the bullish thesis and operational momentum. Removal of $3B in financial contingencies converts backlog to definitive contracts, materially de-risking LEU's revenue base and supporting multiple expansion. HALEU is now a booked business, validated by the X-energy agreement and Oklo LOI, providing prepayments and non-dilutive funding for the buildout.
Keep This Renewable Energy Stock Close Until November
Renewable energy stock Centrus Energy Corp (NYSE:LEU) is trading 5.9% lower at $175.34 this afternoon, extending its pullback after suffering multiple rejections at the $200 level.
Centrus Energy: Uncle Sam Won't Let His Centrifuge Fail
Centrus Energy earns a Strong Buy rating, driven by its critical role in the U.S. advanced nuclear renaissance and government-backed HALEU production. LEU is transitioning from a low-margin broker to a vertically integrated, high-margin nuclear fuel fabrication leader, leveraging co-location with Oklo and Palantir's AIP for CapEx efficiency. Short-term risks include USTR maritime tariffs, Russian export license delays, and DOE funding gaps, potentially creating a temporary liquidity crunch before 2029.
Centrus Energy Q2 Earnings Call Highlights
Centrus Energy NYSE: LEU reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU.
LEU Q2 Earnings Call Highlights Backlog and 2029 Build-Out
Centrus Energy highlights a $4.5B backlog, $900M DOE funding and a 2029 production goal as enrichment demand tightens and Piketon hiring accelerates.
LEU's Q2 Earnings Beat, Revenues up Y/Y on Strong Uranium Sales
Centrus Energy beats Q2 earnings and revenue estimates, but higher administrative and technology costs sharply compress margins.
Nuclear Stock Pick: Here's Why LEU May Have the Edge Over SMR
Centrus Energy and NuScale Power offer contrasting nuclear exposure, with revenues, backlog, valuation and commercialization shaping the comparison.
Prediction: These Will Be the 2 Best Nuclear Energy Stocks to Buy for the Next 5 Years
Nuclear energy is the biggest source of carbon-free electricity in the U.S., providing 47% of the country's zero-emissions power. Nuclear power provides stable and reliable energy to support the electricity grid.
Nuclear Fuel Supply Chain Updates: Centrus Secures DOE Contract
Centrus Energy Corp (LEU) has signed a definitive contract with the U.S. Department of Energy (DOE), a notable update for the entire nuclear industry. Originally selected earlier this year for a $900 million award, the final contract value has expanded to over $1 billion.
